لیست و عناوین مقالات نمایه شده از دومین کنگره بین المللی کنسرژنومیکس به صورت زیر می باشد:
1. Novel PLG and FGA hub genes identified for metastatic liver breast cancer via NGS and Systems Biology techniques
2. Evaluating the Anticancer Potential of Zinc Oxide Nanoparticles Synthesized with Pulicaria gnaphalodes Extract
3. Investigating the Relationship Between Ciprofloxacin Use and Breast Cance
4. Effects of Safflower (Carthamus tinctorius) Extract on Human Prostate Cancer Cells (PC۳)
5. Genetics and epigenetics of ovarian cancer
6. Genetics and Epigenetics of Hodgkin's Lymphoma
7. Molecular Diagnosis Of Ovary Cancer
8. The Impact of BRCA۱ and BRCA۲ Genetic Mutations on Progression and Treatment Response in Inflammatory Breast Cancer
9. Bioinformatic analysis of NFAT۵ gene expression changes in breast cancer
10. Investigating the effect of Auraptene in colorectal cancer cell lines (SW۴۸۰ and HT۲۹)
11. Anti-CD۱۹/CD۸ bispecific T cell engager for the potential treatment of B cell malignancies
12. Targeted therapy of breast cancer: a systematic review
13. Identification of key regulators associated with breast cancer prognosis
14. Glioblastoma Targeted Therapy
15. Molecular diagnosis of Non-Hodgkin’s lymphoma (NHL)
16. Immunotherapy of Multiple Myeloma: Exploring Molecular Mechanisms
17. miR-۱۸۵-۵p potentially mitigates ۵-Fu/DPP chemoresistance via targeting SEZ۶L۲ in colorectal cancer
18. Exploring COL۱A۱, COL۱A۲, FN۱, and MMP۲ as Potential Prognostic Biomarkers in Gastric Cancer
19. A new approach to apoptotic gene expression control using nanoparticle-enhanced wound dressings for antibacterial and anticancer applications
20. Expression alteration and function of long non-coding RNAs in corpus uteri Cancer
21. Genetics and Epigenetics of Corpus uteri Cancer
22. function and expression alteration of lncRNAs in ALL
23. Targeted therapy of lip , oral cavity cancer
24. Advancements in HPV Detection and Characterization: The Promise of NGS and Bioinformatics
25. Investigating the Role of MAPK۱۲ as a Modulator of VEGF in Pulmonary Alveolar Cells in Stage I Lung Adenocarcinoma
26. Clinical Outcomes of CD۳۰-Targeted Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Hodgkin Lymphoma: A Systematic Review
27. Targeted Therapy for Lung Cancer
28. Epigenetic Therapeutics in Osteosarcoma: Combining Histone Deacetylase Inhibitors with Genetic Targeting Strategies
29. Transcriptional biomarkers for early detection of colorectal cancer
30. Regulating of PD-۱/PD-L۱ pathway by LncRNAs in immunotherapy of advanced renal cell carcinoma
31. Can the Synergy of Microneedles Technology and PROTACs Revolutionize Lip Oral Cavity Cancer Treatment?
32. Decoding Glioblastoma Treatment Responses: A Combined Bioinformatics and Machine Learning Study
33. Potential biomarkers for the early detection of esophageal squamous cell carcinoma (ESCC) identified by WGBS
34. Advances in Biomarker-Guided Therapies and Epigenetic Approaches for Esophagogastric and Esophageal Cancers
35. Analysis of CLDN۱ Gene Expression in Colorectal Cancer: Role in Tight Junctions and Tumor Progression
36. Immunotherapy of Acute Lymphoblastic Leukemia in Pediatrics
37. Analysis the role of VEGFA and COL۴A۱ in signaling pathways associated with Glioblastoma progression: Unraveling LncRNA-miRNA axis as high potential biomarkers
38. Investigating the Interaction of miR-۴۶۶۹ and LINC۰۰۷۰۲ with TIMP۱ in Gastric Cancer: Implications for ECM Organization
39. Integrative Analysis of Circulating Tumor Cells Reveals Critical Gene Networks in Lung Cancer
40. Single-Cell RNA Sequencing and Systems Biology Analysis Reveal Cellular Heterogeneity and Immunotherapeutic Targets in Papillary Thyroid Cancer
41. Silencing CD۱۳۳ via siRNA reduces the ability of pancreatic cancer cells in stemness through OCT۴, SOX۲, Nanog genes regulation
42. Therapeutic Potential of lncRNA-PVT۱ Silencing in Enhancing Chemosensitivity and Reducing Lung Cancer Tumorigenicity
43. Unveiling Potential Biomarkers for Gastric Cancer Through Bioinformatics Approaches
44. A New Approach to Breast Cancer Treatment: The Potential of Umbilical Cord Blood Exosomes
45. The Role of Epigenetics in the Mechanisms of Cancer Development and Treatment
46. Drug delivery in glioblastoma cell lines
47. Genetics & epigenetics of gastric cancer
48. A comparative study on anti-cancer potentials of the tamarixetin and quercitrin on Luminal A Breast Cancer
49. Overview of Targeted Therapy for Retinoblastoma
50. The Emerging role of T cell Chemokine Trafficking for the Treatment of Colon Cancer
51. Preclinical Evaluation of Angiogenesis Inhibition in Breast Cancer by htsFLT۰۱/MiRGD Nano complex
52. Genetic and Epigenetic Biomarkers for Lung Cancer: Molecular Mechanisms and Detailed Insights
53. A review on the latest clinical trials of gallbladder cancer
54. Targeted Therapy of Osteosarcoma Cancer: A Review
55. Immunotherapy as an Innovative Approach in Treating CNS Tumors
56. In silico finding of key pathways and genes that are correlated with induction of cancer during aging of blood
57. Molecular dignosis of liver cancer
58. The latest clinical trials of lung cancer immunotherapies: a review of literature
59. The Impact of DNA Methylation Changes in DNA Repair Genes on the Risk of Colorectal Cancer in Patients with Lynch Syndrome Compared to a Control Population
60. Targeted treatment of prostate cancer
61. Prostate Cancer: A Look at Promising Clinical Trials
62. Unraveling the Genetic and Epigenetic Landscape of Pancreatic Cancer
63. New frontiers of CRISPR/Cas۹ system in pancreatic cancer therapy: the current status and future perspectives
64. Salivary Cytokines as Potential Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC): A Review Article
65. Esophageal Cancer: Latest Clinical Trials
66. Evaluation of novel targeted anti-melanoma medications in clinical trials
67. Targeted Therapy in Cervical Cancer
68. Genetic and Epigenetic Insights in Ovarian Cancer: Unveiling Biomarkers and Therapeutic Advances
69. The latest clinical trials for melanoma
70. Molecular biomarkers for early detection and risk profiling of cervical cancer
71. Current Targeted Therapy in Gallbladder Cancer
72. Genetic and Epigenetic Insights in Ovarian Cancer:Unvelling Biomarkers and Therapeutic Advances
73. Molecular Insights into Oral Squamous Cell Carcinoma: An Interplay of Genetic Mutations and Epigenetic Modifications
74. Targeted therapy of Colorectal cancer
75. Using MicroRNA as a biomarker in ovarian targeted therapy
76. Molecular Diagnostic Biomarkers in Brain Cancer: Exploring miRNAs and Proteins in Blood and CSF
77. Review of genetics and epigenetics of Melanoma cancer
78. Innovation Diagnostics Strategies in Non-Hodgkin Lymphoma: Utilizing Exosomes, miRNA Profiling, and Next-Generation Sequencing
79. The Role of Artificial Intelligence in Personalized Targeted Therapy of Thyroid Cancer: An Emerging Frontier
80. The Role of TP۵۳ Gene Mutations in Acute Myeloid Leukemia: Detailed Molecular Mechanisms
81. Advancements in Molecular Diagnostics of Multiple Myeloma: Fundamental Insight to a Path for Better Treatment
82. Application of Genetics and Epigenetics in the Diagnosis and Treatment of Multiple Myeloma
83. MicroRNAs in ovarian cancer , an overview of clinical trials
84. Review of genetics and epigenetics of NHL cancer
85. Evaluation of Larynx cancer risk ratio in Smokers and Nonsmokers : A systematic review
86. An updated genetic and epigenetic aspects of Gallbladder Cancer
87. The role of fibroblast growth factor receptor۱ amplification as a prognostic biomarker in esophageal squamous cell carcinoma: A systematic review
88. The Impact of Thymoquinone on p۵۳ Gene Expression in Breast Cancer, Insights and Therapeutic Potential; A Systematic review
89. Molecular Diagnosis of Lung Cancer
90. Unlocking New Possibilities: Antibody-Drug Conjugates for Bladder Cancer Targeted Therapy
91. The role of obinutuzumab in the treatment of NHL cancer
92. Molecular Diagnosis of Classic Hodgkin Lymphoma
93. Genetics and epigenetics of prostate Cancer
94. Advances in targeted therapy for Hodgkin lymphoma
95. Non-Coding RNAs as Biomarkers for Early Detection and Prognosis of Colorectal Cancer: The Role of miRNAs and lncRNAs
96. molecular diagnosis of gallbladder cancer
97. Targeted therapy of multiple myeloma
98. Exosome-derived circRNAs in early detection of pancreatic cancer
99. Targeted Therapy for Treating Clear Cell Carcinoma of the Corpus Uteri through the Pathophysiology of HER-۲ Gene: A Systematic Review
100. Advances in Cancer Vaccine Development: An Overview of the Latest Clinical Trials in Renal Cell Carcinoma
101. From Code to Chaos: How IDH Mutation Shapes the Epigenome in Gliomas
102. The latest clinical trails of pancreatic cancer
103. Genetics and epigenetics of liver cancer
104. New horizons in kidney cancer: A review of novel targeted and combination therapies from ۲۰۲۰-۲۰۲۴
105. Latest Clinical Trials Review in Laryngeal Cancer: Advances and Insights
106. Deciphering the Molecular Dynamics of Liver Cancer: Insights into Pathogenesis and Therapeutic Opportunities
107. Efficacy of Cetuximab in Laryngeal Cancer Treatment: A Systematic Review
108. Molecular diagnosis of prostate cancer: serum and urine biomarkers
109. molecular diagnosis of laryngeal cancer
110. Genetic Polymorphisms Influencing Cardiotoxicity in Osteosarcoma: Insights into Chemotherapy Response and Toxicity
111. Exploring Molecular Diagnostic Innovations in Breast Cancer: A Systematic Review of Multi-Gene Assays
112. Molecular diagnosis of kidney cancer
113. bladder cancer molecular diagnosis
114. Leveraging Multi-Omics Approaches and Molecular Diagnostics to Accelerate Drug Discovery in Melanoma
115. The Analytical Tool of Artificial I ntelligence, A Method For Early A nd Accurate Detection of Thyroid Cancer: A Meta- A nalysis
116. The Role of Regulated Cell Death Genetic Signatures in Predicting Response to Targeted Therapy for Lung Cancer
117. Molecular Diagnosis of Ovary Cancer
118. The lastest clinical triales: cervix
119. How to improve pain in breast cancer patients? Review of the latest clinical trials
120. Trgeted therapy of oseophagus cancer
121. Advances in Leukemia Clinical Trials: A Genomic and Therapeutic Update
122. Neoadjuvant Treatment With Trastuzumab in HER۲-Positive Breast Cancer: systematic review
123. Targeted therapy of stomach cancer
124. Brain Malignancy: Treatment and Abstacles to Glioblastoma
125. Molecular diagnosis of retinoblastoma
126. SLC۳۴A۲ gene expression changes in renal cancer patients with metastasis
127. Genetics and Epigenetics of Bladder Cancer
128. Genetics and Epigenetics of Thyroid Cancer
129. Pan-Cancer Characterization of Immune-Related lncRNAs: Insights into MAGI۲-AS۳ Regulation and Therapeutic Implications in Colorectal Cancer
130. Examining the results of using FISH technique in diagnosing cytogenetic abnormalities and predicting prognosis in patients with multiple myeloma cancer: A review
131. Molecular diagnosis of Hodgkin lymphoma
132. Recent Advances in Targeted Therapies for Renal Cell Carcinoma: Exploring Molecular Mechanisms
133. Ferroptosis biomarkers, a potential diagnosis in colorectal cancer
134. Genetics and epigenetics of cervix uteri of cancer
135. Harnessing Oncolytic Herpes Virus for Gastrointestinal Cancer Therapy: A Comprehensive Review
136. Harnessing Paracrine Signaling of Guanylin: From Pan-Cancer Analysis to Targeted Therapeutic Nanoplatform
137. Interaction between CHOP, GRP۹۴, and stemness state in gastric cancer samples with Helicobacter pylori infection
138. The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
139. Therapeutic approaches of cell therapy based on stem cells and terminally differentiated cells: Potential and effectiveness
140. Unveiling the Crucial Role of H۱۹ in Testicular Germ Cell Tumor Invasion and Metastasis through Integrated High-Throughput Sequencing Analysis
141. Gold Optical Biosenspors for miRNA Detection in Cancer: A systematic Review
142. Identification of informative Genes in Lung Cancer Stem Cells via Bioinformatics Analysis
143. in silico study on the micro-array data of GSE۳۲۸۶۳ for identifying key overexpressed genes in lung adenocarcinoma
144. Additive effects of Annexin A۵ overexpression in combination with ۵-Fluorouracil in reducing cell viability of Ca Ski cell
145. Neutrophil to Lymphocyte Ratio in Meningioma: A Systematic Review and Meta-Analysis
146. Evaluation of Tumor Markers in Endometrial Cancer Differentiation and Abnormal Uterine Bleeding
147. Evaluation the surgical techniques and endocrine-reproductive outcomes of ovarian transposition prior to pelvic radiotherapy
148. The effect of m۲ peptide targeted nanoliposomes containing crocin on induction of phenotypic change in tumor macrophages to M۱ state
149. hsa-miR-۳۲۶ has a different expression pattern in MCF-۷ cells and the MCF-۷-derived small extracellular vesicles
150. Evaluation of The Importance of Non-High-Risk Human papillomavirus in High-Grade Cervical intraepithelial neoplasia
151. Analysis the role of some effective microRNAs on the Hippo signaling pathway in Chronic Myeloid Leukemia K۵۶۲ cell line treated with NVP-AUY۹۲۲
152. The relationship between genetically modified foods and Gastrointestinal cancer: A systematic review of randomized controlled trials
153. Single Cell RNA Sequencing Reveals B Cells, T Cells, NK Cells, Hepatocytes and Neutrophils Associated with Progression of Inflammatory Bowel Disease from Mucosa to Crohns Disease
154. Bioinformatics Analysis and Machine Learning Approach Applied to the Identification of Novel Prognostic MicroRNAs in Sarcoma
155. Epigenomic Silencing of Multiple Critical Genes in Breast Cancer with CRISPRoff and Genetically-Modified HIV-۱/Herolizin Vector
156. MicroRNAs as valuable biomarkers in early diagnosis, prognosis, and targeted therapy of oral cavity cancer
157. Targeted therapy by molecular biomarkers in liver cancer patients
158. Liquid biopsy is the resource of molecular biomarkers in the clinical approaches of oral cavity cancer
159. The role of nutritional interventions on cancer incidence and mortality: A systematic review of randomized controlled trials
160. Unlocking the Anti-Cancer Potential of Silibinin: A Network Pharmacology and Experimental Approach for Colorectal Cancer Treatment
161. Evaluation of the effect of magnetic nanoparticles loaded ۵_fluorouracil (۵-FU) on colon cell line LS۱۷۴T
162. Genetic Variants in DNA Repair Pathways: Implications for Platinum-Based Chemotherapy in Breast Cancer
163. Clinical pathway of bladder cancer
164. The impact of copper nanoparticle on breast cancer: An in vitro model
165. Identifying CDK۱ and EZH۲ as potential therapeutic targets for breast cancer through WGCNA
166. An Approach in Radiation Therapy Treatment Planning: A Fast, GPU-Based Monte Carlo Method
167. Long-term Antibiotic Use and Gastric Cancer Risk: An Investigation
168. Overexpression of the GABBR۱ gene in AML patients: A correlation with chemoresistance
169. Potential Environmental Carcinogens in Iran
170. Potential Environmental Carcinogens in Iran: A Brief Review
171. Extracellular vesicles derived from RAW macrophage cell lines loaded with ۴T۱ cell lysate for prophylaxis and treatment of mouse tumor
172. Cell death classification: A new insight based on molecular mechanisms
173. The Impact of CYP۲D۶ Gene Polymorphisms on the Metabolism and Efficacy of Imatinib in Patients with Chronic Myeloid Leukemia (CML)
174. Investigating the Role of Genetic Variants in Sensitivity to Immunotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC)
175. Recent Advances in RGD Peptide conjugated nanoparticles system as a new strategy for Targeted Therapy in Colon Cancer
176. Examining the variance in mTOR۱/UCA۱ expression levels between tumor specimens of colorectal cancer and adjacent tumor margin specimens
177. Investigation of the Association between the rs۱۱۶۶۱۴۹۱۳ Polymorphism and the Probability of Developing Lung Cancer in the Iranian Population
178. Genetic and Epigenetic Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
179. Investigating the Expression Levels of Bcl_۲, Bax, and Fas Ligand (FasL) Genes in Patients with Colon Cancer
180. Expression alterations and function of long non-coding RNAs in breast cancer among the Iranian population
181. Probiotics, As New Agents For Cancer Therapy
182. Reduction of PKHD۱L۱ gene expression in thyroid cancer and its relationship with tumor invasion
183. The Impact of DNA Methylation Changes in DNA Repair Genes on the Risk of Colorectal Cancer in Patients with Lynch Syndrome Compared to a Control Population
184. Identification the novel hub genes in metastatic gastric cancer to Ovarian tissues by Bulk-RNA-seq techniques
185. An Optimized Method for Single Cell Cloning of Human CAR-T Cells based on FBS-coated Plates
186. In-silico investigation of p. Pro۱۲۳Arg missense mutation in the SOCS۱ gene and its effect on the development and appearance of tumorigenesis
187. Strategies to increase systemic toxicity in melanoma cancer treatment
188. Investigating the Regulatory Role of miRNA, SNP, and lncRNA on TP۵۳BP۲ Expression in MAP۳۰-Treated Bladder Cancer Cells Using Bioinformatics
189. an article review of genetic and epigenetic factors in prostate cancer
190. New Therapies for Advanced Thyroid Cancer
191. Dysregulated Expression of miRNA-۲۲۱, miRNA-۲۱, and lncRNA H۱۹ as Potential Predictors of Treatment Response and Gastric Cancer Progression in H. pylori-induced Gastric Ulcers
192. BGN (biglycan) as a Potential Prognostic Biomarker in Colon Adenocarcinoma (COAD): The Cancer Genome Atlas Transcriptomic Analysis
193. A girl with Burkitt Lymphoma and complex karyotype
194. Targeted Therapy in Hodgkin Lymphoma: A Promising Frontier
195. The Impact of Brain Tumor Type on Sleep Patterns and Quality of Life in Patients Undergoing Radiotherapy Abstract
196. Lifestyle Choices and Breast Cancer: The Influence of Diet, Exercise, and Alcohol Consumption on Risk Reduction
197. Investigating the relationship between the expression of DDX۲۱ and mir۲۰۰a genes with the prognosis of colorectal cancer patients
198. The Role of Molecular Mutations in Determining Sensitivity to Targeted Therapy in Bladder Cancer
199. Evaluation of the Impact of Genes Involved in Immune System Regulation on the Prognosis of Patients with Hodgkin's Lymphoma
200. Prognostic Value of MMP-۱۳, miR-۱۳۸, and miR-۱۳۸-۵P in Breast Cancer: A Study of Iranian Women
201. Stage-Specific Molecular Diagnostics for Liver Cancer
202. Identifying Effective Pathways and Genes in Colorectal Cancer by Analyzing Microarray and RNA Sequencing Data
203. Specific Targeting of Recombinant Human Pancreatic Ribonuclease ۱ using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells
204. Evaluation of anti-cancer properties of microcapsules containing Arctium lappa bioactive compounds
205. investigating the cytotoxic effects of synthesized green cerium oxide nanoparticles on glioma and normal fibroblast cells: separation of nanoparticles by a different and new method
206. Identification of potential inhibitors of Aromatase using molecular docking simulation related Breast cancer (BC)
207. Investigating the relationship between ABO blood group and Ovarian Epithelial Cancer(EOC)
208. Leveraging Digital Twins and GEO Data for Cancer of Unknown Primary (CUP) Treatment
209. FKBP۵۱ and Cancer Stem Cells: Coordinating Cancer Progression through the Molecular axis
210. The latest clinical trials of retinoblastoma cancer
211. Liver Cancer Immunotherapy
212. Molecular diagnosis of osteosarcoma: A review
213. Clinical pathway of esophageal squamous cell cancers
214. Identifying Genetic Mutations in Retinoblastoma Cancer: A Clinical Pathway Approach
215. Artificial Intelligence in Cancer Research: Applications and Advancements
216. Genetics and epigenetics of retinoblastoma cancer
217. Evolving Therapies for Hepatocellular Carcinoma: The Role of Tyrosine Kinase Inhibitors and Combination Treatments
218. Biosynthesis of Silver Nanoparticles Using Oscillatoria Extract and Evaluation the Anticancer and Antibacterial Activities
219. Galbanic acid-encapsulated PLGA Nanoparticles modulate apoptotic-related genes in colon cancer (SW۴۸۰)
220. Combination Therapies in the Treatment of Advanced Esophageal Cancer: Insights from Recent Clinical Trials
221. lncRNAs, a key regulator of the MAPK signaling pathway in gastric cancer
222. Hyaluronic acid-based nanodiamond coated with gold nanoparticles and loaded with doxorubicin can enhance targeted cancer therapy
223. Targeting Breast Cancer Stem Cells with CRISPRi-mediated NOTCH۱ Inhibition and Genetically-modified Adenovirus Delivery
224. Circulating tumor DNA: A non-invasive approach to cancer detection
225. Correlation between MYH۱۱ expression and clinicopathological features of ESCC patients
226. Identification and Analysis of Crucial Genes Underlying pancreatic cancer via Bioinformatics Techniques
227. Combined Effects of Hesperidin and Quercetin on Apoptosis in HepG۲ Cell Line
228. In Silico Evaluation of Pistachio Peel-Derived Phenolic Compounds as Anticancer Agents Against TLR۴ and STAT۳ in Breast Cancer
229. Genetic and Epidemiological Factors in Breast Cancer Incidence Among Women with a Family History
230. Clinical pathway of melanoma cancer
231. Investigating the relationship between serum progastrin level and clinical-pathological status in patients with colorectal cancer
232. AURKA as a druggable hub gene for treating Vulvovaginal melanomas: in silico study
233. Interaction between CD۱۶۱ and Vα۷.۲-Jα۳۳ in Gastric Cancer Cells with Helicobacter pylori Infection
234. Pan-Cancer Insights into HAND۲-AS۱ LncRNA: Tumor Suppressor, Prognostic Biomarker, and Immunotherapeutic Target
235. PRKG۲ as a Potential Therapeutic Target for Eradicating Melanoma cell and Senescent Melanocytes: In silico study
236. Exploring the Anti-Cancer Potential of C۶۰ Fullerene: Apoptosis Induction, Cell Cycle Arrest and ROS-Dependent Cell Death in Human Glioblastoma U-۳۷۳ Cell Line.
237. Delivery of htsFLT۰۱ to Y۷۹ Cells by MiRGD peptides and Graphene Quantum Dots
238. Identification of key regulatory networks and prognostic biomarkers in Stomach Adenocarcinoma; a comprehensive analysis based on RNAseq data
239. Telomerase and mitochondria inhibition promote apoptosis and TET۲ and DNMT۳a expression in triple negative breast cancer cell lines
240. Differentially expressed genes by microarray analysis in Stomach cancer samples
241. RPS۱۹ Gene as a Novel Biomarker in Breast Cancer
242. The latest clinical trials of melanoma vaccination : A review
243. Identification of LncRNA-microRNA-mRNA Network in Non-small Cell Lung Carcinoma through Bioinformatics-Based Tools
244. The Amplified Peril: How Excessive Alcohol Consumption Escalates the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
245. Meta-Analysis of Gene Expression Datasets Reveals Key Differentially Expressed Genes and Enriched Pathways in Anaplastic Thyroid Cancer
246. The Impact of FMR۱ Gene Mutations on Fertility in Women with Type ۲ Epithelial Ovarian Cancer: A Case-Control Study Including Hormonal Assessments and Gene Expression Analysis
247. Esophageal cancer
248. The Role and Function of lncRNAs in the Development and Treatment of Hodgkin Lymphoma: Molecular Analysis and Therapeutic Applications
249. dual-functionalized delivery nanocomplex system for the transport of doxorubicin to cancer cells through the use of AS۱۴۱۱ aptamer and hyaluronic acid polymer that comprised polyethyleneimine and FOXM۱ aptamer
250. Identification of microRNAs influencing triple-negative breast cancer through bioinformatics analytical approaches
251. Gene Regulation in Hepatocellular Carcinoma: The Interaction of miR-۱۲۷۰ and SLC۳۵A۲
252. The latest breast cancer clinical trials and Metformin
253. Identification of hsa-mir-۱۸۳ and hsa-mir-۱۳۹ as two potencial candidates for therapeutic aims in breast Cancer through bioinformatics and machine learning approaches
254. EPH Receptor B۱ gene expression is linked to the survival of PTC patients
255. Immunotherapy of Pancreatic cancer
256. The link between FGFR۱/FGFR۳ and Ras gene mutations and the pathological tumor grades in oral squamous cell carcinoma in Iranian patients
257. The Emerging Role of Copper Metabolism and Cuproptosis in Human GI cancers
258. The genetic and epigenetic aspects of renal cell carcinoma treatment
259. The Role of MicroRNAs in Lip and Oral Cavity Cancer: Molecular Mechanisms, Diagnostic Biomarkers, and Therapeutic Potential
260. Pathogenicity prediction of a missense mutation (p.Ser۲Gly) in ATM gene associated with Leukemia
261. The use of living tumor cells producing IL-۲ and GM-CSF as a new therapeutic approach to change the immunosuppressive tumor microenvironment in glioblastoma
262. Studying the expression of Hsa_circ_۰۰۷۵۳۴۱ and miR-۱۴۹-۵p in tumor tissue of breast cancer patients compared to normal tissue
263. Exosomes released from U۸۷ glioma cells treated with ۵-fluorouracil produce apoptosis in naïve U۸۷ cells
264. The combination of Doxorubicin and Coumarin can suppress the growth of colorectal cancer cells: In silico and In vitro study
265. Forecasting mutations in the telomerase reverse transcriptase promoter associated with glioma: A comprehensive systematic review and diagnostic meta-analysis utilizing machine learning algorithms
266. Expression alternation and functional of long non-coding RNAs in multiple myeloma cancer
267. Application of targeted therapy in treatment of leukemia
268. Expression alternation and function of small non-coding RNAs in Thyroid cancer
269. Expression alteration and function of small non-coding RNA in retinoblastoma
270. Identification of potential key genes and enriched pathways in lung adenocarcinoma via integrated bioinformatics analysis
271. In-silico Pathogenicity Analysis of p.Arg۱۸۴H Missense Mutation ( rs۱۲۱۹۱۸۳۵۱) in JAG۱ In-silico Pathogenicity Analysis of p.Arg۱۸۴H Missense Mutation ( rs۱۲۱۹۱۸۳۵۱) in JAG۱
272. Molecular diagnosis of melanoma cancer
273. MicroRNA Therapeutics and Non-Coding RNAs in Hepatocellular Carcinoma: A Path Toward Precision Medicine
274. Senescence, a double-edged sword in cancer biology, With focused on the role of BIRC۵ in hepatocellular carcinoma
275. LncRNAs as Key Drivers in Clear Cell Renal Cell Carcinoma
276. The importance of variants and network interactions in the progression of colorectal cancer
277. The Anti-Cancer Effects of Hydatid Cyst: A Review
278. The Perturbation of Tumour Microenvironment in Pancreatic Ductal Adenocarcinoma in Response to the Chemoradiotherapy: Insights from single-cell RNA sequencing Analysis with Focus on Lymphoid Lineage
279. Impact of Key lncRNAs on Thyroid Cancer Development and Treatment
280. Genetic and Molecular Mechanisms in Colorectal Cancer: Pathways to Targeted Therapies
281. Long Non-coding RNA as a Molecular biomarker for diagnosis and treatment of Stomach cancer
282. Expression alteration and function small noncoding RNAs in gastric cancer
283. The Impact of Flaxseed Extract on the Expression of DNA Repair Genes MSH۲ and MLH۱ in Breast Cancer Cells
284. From bench to bedside: breakthroughs in targeted therapies for multiple myeloma
285. Studying the effect of CDH۲-i۲ miR-۲ and CDH۲-i۲ miR-۳,on cell migration
286. In Silico Analysis of the Molecular-Level Impact of NPM۱ Protein Variants on Acute Myeloid Leukemia
287. A Review of the Role of Long Non-Coding RNAs in Esophageal Cancer
288. Design of an Atezolizumab Nanobody and Targeted Mutagenesis for Enhanced Binding to the PD-L۱ Antigen
289. Design of an Avelumab Nanobody and Investigation of Its Binding to the PD-L۱ Antigen
290. Upregulation of SQSTM۱(P۶۲) correlates with tumor progression and autophagy in gastric cancer; A bioinformatic study
291. The Role of lncRNAs in Ovarian Cancer: Biomarkers, Chemoresistance, and Therapeutic Targets
292. In silico Analysis of Suitable Immunogenic WT۱ Epitopes in Iranian Population for Targeted Immunotherapies
293. APOBEC۳B as a Key Biomarker in Cervical Cancer: Insights into HPV, HIV, and Genetic Instability
294. CA۹ as a Biomarker in Kidney Cancer: Role in Carbonic Acid Metabolism and Regulatory RNAs
295. Combining two novels lncRNAs and mRNAs signatures for prognostic Assessment in Mouth neoplasms: Discoveries from FBXO۲۲ and BYSL Genes
296. Long Non-Coding RNAs in Leukemia: A Novel Frontier for Diagnostic Biomarkers
297. Investigating the effect of coumarin on the expression of selected cellular lncRNAs (lncRNA-H۱۹, RNCR۳, and LINC۰۰۶۵۷) and their target genes (miR-۴۹۱-۵p, miR-۱۹۰a-۳p, PTEN, and miR-۱۸۵-۵p) in gliobla
298. An In Silico Approach to Identify Candidate tRNA-Derived Fragments with Minimal Modifications as Potential Biomarkers for Early Cancer Detection Studies
299. mRNA and lncRNA axes in the ceRNA network promote the development of clear cell renal cell carcinoma through CD۳۶ up-regulation in platelet activation, signaling, and aggregation
300. inciting changes in the expression of miR-۱۸۱a-۵p, PTEN, and PI۳k in the Jurkat cell line using Cassiopeia andromeda toxin, one or all?
301. Genetics And Epigenetics Of Liver Cancer
302. Molecular Diagnosis of Retinoblastoma Cancer: A Review
303. Study of SCNN۱A and SCNN۱G DNA Methylation at Blood Leukocytes as Potential Epigenetic Biomarkers for Bladder Urotherial Carcinoma (BLCA)Diagnosis
304. The evaluation of the effect of β-glucan nanoparticle coated with doxorubicin on colon cancer cells
305. Evaluating the effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaloplatin on ovarian cancer (OVACR۳) cell line
306. Dissecting the Molecular Complexity: Insights into the Mechanisms Underlying Kidney Cancer
307. The Role of N۱۱۶S Mutation in KRAS Gene and Its Regulation by Hsa- miR- ۵۵۸۶-۵p in Lung Adenocarcinoma (LUAD)
308. Identification of lncRNA-miRNA-mRNA ceRNA network as biomarkers for lung adenocarcinoma
309. miR-۲۱-۵p / SESN۱, axis involved in radiosensitivity of Breast cancer cells treated with metformin
310. Investigation of CD۱۹+CD۲۱low B-cells expansion in primary immunodeficiencies
311. Antitumor activity of hydatid cyst fluid antigens on BALB/c mice with Breast Cancer
312. Investigating the effect of anti-Toxoplasma gondii antibodies on breast cancer
313. Application of artificial intelligence and machine learning algorithms in identifying genetic mutations associated with drug resistance in cancer
314. Antitumor Activity of Hydatid Cyst Fluid Antigen B on Tumors Induced by MCF۷ Breast Cancer Cell in BALB/c Mice
315. Unraveling Prognostic Signatures in Lung Adenocarcinoma: Insights from Extracellular Matrix-Related Genes
316. The effect of Plasmodium berghei on intestinal cancer suppression in BALB/c mice
317. The latest clinical trials of osteosarcoma: A review
318. Targeted therapy of gastric cancer: The efficacy of fam-trastuzumab deruxtecan-nxki on HER۲-positive gastric cancer
319. SAMMSON lncRNA: A Critical Link in Melanoma Development and Therapeutic Resistance
320. Biomarkers of Laryngeal Cancer: Innovations in Diagnosis
321. Targeted Therapy of Osteosarcoma: A Review
322. Molecular Diagnostics and Personalized Therapeutics in Thyroid Cancer
323. Determine Frequency of PIK۳CA common mutations in Iranian Breast Cancer Patient
324. Immunotherapy of Esophagus Cancer
325. Comparative Pathway Analysis of Glioblastoma and Astrocytoma Through Differential Gene Expression
326. Exploring the relationship between CNTN gene expression and Glioblastoma with bioinformatic data
327. Expression Alternation and Function of Small Non-coding RNAs in Osteosarcoma Cancer
328. The lastest clinical trails of Ovary cancer
329. research article
330. Overview in Thyroid Cancer Treatment with a Focus on Targeted Therapies
331. Efficient and low-risk treatment of skin cancer using antibacterial nanoparticle loaded film containing anti-cancer drug and expression changes of apoptotic genes
332. Small non-coding RNA signature in kidney cancer: The role of MicroRNA as a biomarker in Renal Cell Carcinoma
333. Expression Alterations and Functions of Long Non-Coding RNAs in Retinoblastoma
334. Immunotherapy of NHL cancer
335. Role of small non-coding RNAs in lung cancer: a Meta analysis of small RNAs expression profiling
336. Comparison of Vitamin D, Calcium, Parathyroid Hormone (PTH) and Osteocalcin changes in Breast Cancer Patients and Normal People
337. clinical pathway of thyroid cancer
338. Therapeutic Potential of HTLV-۱ Reverse Transcriptase Inhibitors in Glioblastoma Treatment: A Telomerase-Targeting Approach
339. Design and identification of miRNA with a server RNAhybride for different transcripts of Ras gene in colorectal cancer
340. Differential Gene Expression and Co-expression Network Analysis Reveals CKAP۲L and NCAPH as Key Regulators in Low-Grade Gliomas
341. Investigation of the immunological evasion mechanism of papillary thyroid cancers and identification of the pivotal gene implicated in disease recurrence
342. Targeted Therapy of Pancreatic Cancer: Overcoming the challenges by Nanoparticle-Based Drug Delivery Systems
343. Unveiling Genetic Biomarkers: The Role of rs۷۴۹۹۳۷۰۴۲ and CYP۲C۹ in Hepatocellular Carcinoma Development
344. A Review of the Expression and Function Changes of sncRNAs in CNS Brain cancer
345. Expression level of long non-coding RNAs MALAT, PVT۱, and HOTAIR and their targets in cervical cancer cells treated with Coumarin plus Oxaliplatin
346. Uterine cancer: different types, latest clinical trials, and side effects on women's fertility
347. Using Machine Learning for Prevention and Early Detection of Colorectal Cancer
348. Targeted mutagenesis with the aim of improving the binding of Avelumab antibody to antigen in cancer inhibition
349. Combination of Nanobiosensors and Machine Learning for Cancer Detection: A Comprehensive Review
350. Addressing Left Censoring in Cancer Genomics: A Semi-Supervised Learning Approach
351. Evaluation of expression levels of lncRNAs GAS۵, CRNDE and HOTTIP as well as their targets (miR-۱۸۲‑۵p, miR-۱۸۱a-۵p, Bcl-۲, EZH۲ and p۲۷) in coumarin-treated colon cancer cells
352. Rs۷۶۶۳۸۸۰۷ hinder PAG۱'s ability to promote CSK activation in DLBLC patients
353. Identification of key genes and signaling pathways involved in metastatic peritoneal cancer originating from gastric and pancreatic cancers: A bioinformatics study
354. Expression alternation and function of long non-coding RNAs in NHL cancer
355. Apoptotic effect of supernatant of pre-conditioned bone marrow-mesenchymal stem cell by nano-silymarin against melanoma
356. Unveiling the Prognostic Potential of Metabolic Genes in Lung Adenocarcinoma
357. The last clinical trials for NHL
358. The latest clinical trials of Cervix Uteri Cancer
359. A Gene in Naked Mole Rat that Prevents Cancer in Humans
360. Long Non-Coding RNAs: Promising Biomarkers for Lip and Oral Cavity Cancer
361. Investigating the Genetic Effect of HLA on the Response to Immunotherapy in Patients with Classic Hodgkin Lymphoma
362. Targeted therapy of kidney cancer
363. Expression alternation and function of long non coding Rna in gastric cancer
364. Immunotherapy: as a novel pathway in treatment of breast cancer
365. Expression alteration and function of lncRNAs in brain CNS cancer
366. Silent Sentinels of Tumor Biology: Unveiling the Protective and Regulatory Roles of Small Non-Coding RNAs in Gallbladder Cancer and the Promise of Gene Editing
367. Targeted Docetaxel Delivery Using Modified Copper Sulfide Nanoparticles: Evaluation In vitro
368. Challenges and Prospects of CAR-T Cells in Cancer Immunotherapy
369. Whole exome sequencing (WES) in a Blast phase Primary Myelofibrosis (PMF-BP) patient, identified alterations which may affect epigenetic reprogramming in the context of leukemogenesis models
370. ADAM۱۰: A Key Extracellular Matrix Gene Influencing Esophageal Cancer Survival
371. Dendrosomal nanosolanine affects the PI۳K pathway in colorectal cancer
372. Epiregulin (EREG) gene expression in Breast Cancer patients
373. onquering Glioblastoma: The Revolutionary Impact of Nanomedicine on Treatment
374. Targeted therapy of Cervix Uteri Cancer
375. Recent Advances in Clinical Trials for Multiple Myeloma: A Comprehensive Review
376. hsa-miR-۳۷۰-۳p regulates the Phospholipase C-mediated Cascade pathway in the Colorectal cancer development by modifying the expression of FGFR۳: Integrated High-throughput bioinformatics investigation
377. Identifying Hub Genes and MicroRNAs as Potential Biomarkers for Pediatric Glioblastoma: A Bioinformatics Analysis
378. The effect of different LSD۱ (KDM۱A) gene inhibitors on lung cancer treatment
379. Investigating the Impact of MYC Gene Promoter Methylation and IKZF۱ Gene Body Methylation on Disease Progression and Drug Resistance in High-Risk Multiple Myeloma Patients
380. Exosomal microRNA signatures as diagnostic biomarker in cervical cancer: a novel screening tool
381. In-situ forming composite hydrogel consist of pH-responsive doxorubicin-loaded nanogel and combretastatin A۴ loaded liposome for breast cancer treatment
382. Insights on recent advances in immunotherapy of bladder cancer
383. Identification of hub genes and MicroRNAs as novel biomarkers in pilocytic astrocytoma in pediatrics using integrated bioinformatics
384. Targeted therapy of ovary cancer
385. Targeted Therapy of Gallbladder Cancer: Leveraging Tumor-Associated Macrophages for Precision Drug Delivery
386. Identification of key biomarkers and MicroRNAs in cutaneous squamous cell carcinoma via bioinformatics analysis
387. The expression level of IFI۶ gene in Breast cancer patients regulated by mir-۴۲۹۸
388. Comparative study of microarray analysis in gastrointestinal carcinomas: identification of common genes and signaling pathways
389. LncRNA SNHG۱۱,A Novel biomarker of resistance glioblastoma
390. Finding a novel gene in kidney cancer
391. Targeted therapy of NHL cancer
392. Biocompatible Nanoparticle-Enhanced Wound Dressings: A Novel Strategy for Gene Expression Modulation in Dual Antibacterial and Anticancer Therapies
393. Study of PTEN Gene Expression Changes in Glioblastoma Cells Following Chemotherapeutic Intervention
394. Immunotherapy in Hodgkin Lymphoma: Molecular Mechanisms and Clinical Implications
395. Personalized approach of malignant central nervous system tumors in the era of copy number variations co-occur with other genetic alterations
396. Investigating the Role of ADAM۱۰ in Prognosis of Kidney Renal Clear Cell Carcinoma Patients
397. The Effect of hsa-miR-۶۷۳۰-۵p on COL۱A۲ Gene Expression in Liver Cancer: Mutation Impact on Protein Function
398. Diagnostic biomarkers in prostate cancer
399. STAT۳ in pre-cancer inflammatory processes
400. Identification of FGF۱۹ and CTNNA۲ as Novel Dual-Gene Signatures for Early and Late-Onset Colorectal Cancer Diagnosis: A Systems Biology Approach
401. Molecular diagnosis of lung cancer
402. Expression alternation and function of long non coding RNAs in larynx cancer
403. Topic: Genetics and epigenetics of thyroid cancer
404. Clinical pathway of liver cancer
405. Nanocapsule Delivery of Glycyrrhiza glabra L. Bioactive compounds: A Novel Approach to Induce Apoptosis in Pancreatic Cancer Cells
406. Expression Alteration and Function of Long Non-Coding RNAs in Liver Cancer
407. Genetic and Epigenetic of Colorectal Cancer (CRC); a review research
408. Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine
409. Antitumor activity of exosomes derived from Toxoplasma infected cells on BALB/C mice induced with intestinal cancer
410. An in silico approach in designing siRNA based nano-therapy in gastric cancer
411. Metabolic Signature Genes: Prognostic Insights for Kidney Cancer Survival
412. Topic: The latest clinical trials of colorectal cancer
413. Dosimetric Comparison and Risk of Skin Toxicity in Breast Cancer Radiotherapy: Conventional vs. Hypofractionated Approaches
414. Gastric Cancer: Gene Expression Analysis of CEMIP
415. Investigation of AKT Expression in Glioblastoma Treated with Nanofiber Containing PAN Polymer, ZnO Nanoparticles, and TMZ
416. The effect of Bacillus licheniformis bacterium extract isolated from the Salt Lake of Qom province on the expression of BAX, BCL۲ genes in MCF-۷ cancer cell line
417. Bridging the Gap: Linking Molecular Pathways to Therapeutics in Ovarian Cancer
418. effect of lncRNAs in bladder cancer
419. Bioinformatics Analysis Reveals Potential Biomarkers for Esophageal Cancer
420. Discovery of Novel microRNA and lncRNA Biomarkers for Prognosis and Diagnosis in Stomach Adenocarcinoma: An Integrative Bioinformatics and Systems Biology Approach
421. Bioinformatic Analysis of Changes in TP۵۳ and hsa-miR-۱۲۲-۵p Expression and Their Interaction in Gastric Adenocarcinoma
422. Disulfidptosis and Its Impact on Acute Myeloid Leukemia: A Study of Gene Expression and miRNA Interactions
423. Molecular Diagnosis of Long non-coding RNA LINC۰۱۱۱۷ in Breast cancer
424. clinical pathway of hodgkin lymphoma cancer
425. From Exposure to Prevention: The Role of Biodosimetry in Cancer Risk Management
426. Genetics And Epigenetics Of NHL
427. Immunotherapy of gallbladder cancer
428. The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function
429. Investigating the genetics and epigenetics of corpus uteri cancer
430. Genetics and epigenetics of bladder cancer
431. Comparative Analysis of TRPM۱ and hsa-miR-۱۹۳a-۵p: Exploring Their Roles as Potential Biomarkers and Oncogenes in Melanoma
432. MicroRNAs as potential prognostic biomarker in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
433. Correlation study of increased gene expression between long non-coding RNA and CircRNA in gastric cancer
434. Expression alternation and function of small non-coding RNAs in esophagus cancer
435. Investigating the risk factors of breast cancer in women referring to the surgical clinics of Babol hospitals in the years ۱۳۹۰-۱۴۰۰
436. Relationship Between Important Genes in the Hepatocellular Carcinoma Pathway and Circular RNA
437. WEE۱ Kinase Dysregulation in Glioblastoma: Insights into Cell Cycle Control and Post-Transcriptional Regulation through hsa-miR-۶۱۹-۵p and LINC۰۰۳۲۴
438. The influence of ERBB۴ gene expression and its genetic modification on kidney renal cell carcinoma
439. Molecular diagnosis of Esophageal squamous cell carcinoma
440. Clinical Pathways of Stomach Cancer
441. Bioinformatics and laboratory analysis of miR-۵۰۵ and miR-۲۱ expression correlation in glioblastoma
442. A Personalized Decision-Support Framework for Predicting Immune Checkpoint Blockade Efficacy Using Ensemble Learning and Explainable AI
443. Comprehensive Review of Lipid Nanocapsules for Drug Delivery in Cancer and Therapeutic Potential
444. Extracellular Region Alterations in Gastric Cancer: Insights from RNA-seq Analysis and Biomarker Discovery
445. Latest immunotherapy of gastric cancer
446. Influence of Perivascular Adipose Tissue on Atherosclerotic Smooth Muscle Cell Phenotype Switching in Cancer Progression: Unraveling the Atherosclerosis-Cancer Link Through a Multi-Omics Approach
447. EGFR inhibitors in colorectum cancer targeted therapy
448. PIWI-interacting RNAs (piRNAs) as potential biomarkers in bladder cancer
449. In-Silico Analysis of CDC۴۵ in Triple-Negative Breast Cancer progression
450. Clinical pathway of kidney cancer
451. Bioinformatic and experimental analysis of anticancer activity of Streptomyces iranensis UTMC ۱۰۱ against MCF-۷ cell line
452. E۲F۳-related targets for retinoblastoma molecular therapy
453. The effects of long non code RNAs in pancreas cancer
454. Differential genes expression and co-expression network analysis in colorectal cancer: A new approach to identify therapeutic targets
455. Reprogramming Tumor Biology: Targeting Epigenetic Pathways in Pancreatic Cancer
456. expression alternation and function of small non coding RNAs in larynx cancer
457. Predicting the interaction of hsa-miR-۱۳۳b in NELL۲ gene and also express this gene in ovarian cancer through bioinformatics analysis
458. Clinical pathway of Non-hodgkin lymphoma cancer
459. Investigation of coexpression correlation miR-۴۲۱ and miR-۲۱ in glioblastoma cell lines using bioinformatic and laboratory methods
460. Machine Learning-Based Diagnosis of Early and Advanced Stages in Triple-Negative Breast Cancer
461. Enhancer RNAs in Acute Myeloid Leukemia: Potential Diagnostic Biomarkers Revealed by RNA-Seq
462. Identification of Key Long Non-Coding RNAs and Gene Networks in Acute Myeloid Leukemia: A Bioinformatics Approach
463. Gold nanobiosensors for the detection of colorectal cancer: A novel approach to diagnosing the disease
464. The Potential of Curcumin in Cervical Cancer Treatment: An Innovative and Complementary Approach to Enhance the Efficacy of Conventional Therapies
465. Advances in Artificial Intelligence and Biomarker Detection for Early Diagnosis and Management of Gallbladder Cancer
466. Utilizing RNA Sequencing Data for Genetic Insights and Drug Repurposing in Prostate Cancer
467. Clinical Pathway of Leukemia Vaccines: Advances and Future Directions
468. The Application of Next Generation Sequencing in Gliomas: A Systematic Review of Diagnostic and Therapeutic Implications
469. Expression Alternation and Function of Long non Coding RNAs in Gallbladder Cancer
470. In vivo CAR T cell therapy; An alternative solution
471. Advanced nanotechnology in enhancing immune checkpoint blockade for laryngeal cancer therapy
472. immunotherapy of brain (CNS) cancer
473. The impact of diagnostic tests such as ctDNA on the treatment of breast cancer
474. Immunotherapy of brain (CNS) cancers
475. The latest clinical trials of stomach cancer treatment
476. Effect of KRAS, TP۵۳, SMAD۴, CDKN۲A as diagnostic biomarkers for PDAC cancer
477. The latest clinical trials of gemcitabine in biliary tract cancer
478. Autophagy-HPV-DNA Methylation modifications; A chain for Cervical Cancer pathogenesis
479. Mechanistic Insights into Gemini-Cur Enhanced Therapeutic Efficacy in Colorectal Cancer: The Role of Differentially Expressed lncRNAs
480. Application of Iron Oxide Nanoparticles in Immunotherapy of Liver Cancer
481. VarDrug: Predicting Variant-Drug Interactions to Enhance Personalized Drug Safety
482. Immunotherapy, A Novel and Effective Approach for Treating Retinoblastoma and Preserving Vision
483. Role of MMP۷ in Colorectal Cancer: Expression, Pathway Interactions, and SNP Impact
484. clinical pathways corpus uteri cancer
485. Investigation the interaction between hsa-miR-۱۵۳-۳p and BCL-۲ gene in cervical cancer progression via bioinformatical analysis
486. Prediction of Lymphovascular Invasion in Non-Small Cell Lung Cancer Using Multiomics Data
487. Molecular Mechanisms in Laryngeal Cancer: A Review of Genetic and Epigenetic Alterations
488. An analysis of TCGA RNA-seq datasets to identify differentially expressed genes in glioma
489. Immunotherapy of thyroid cancer
490. clinical pathway of cancer - osteosarcoma
491. Drug release from PLGA microspheres: recent advances in preparation, mechanism, and modification
492. Identification of Biomarkers for Lung Adenocarcinoma with Molecular Docking Analysis Targeting Topoisomerase II Alpha as a Key Protein in Hub Gene Network
493. MicroRNA's in Multiple Myeloma: Drivers of Drug Resistance and Therapeutic Targets
494. Expression alternation and function of small non coding RNAs in cervical cancer
495. Design of a New Inhibitory Ligand for Bcl-۲-Induced Apoptosis to Enhance Breast Cancer Treatment Using Bioinformatics Tools
496. Bioinformatic identification of products from GIMAP family genes as predictive biomarkers for glioblastoma tumors
497. Perspectives on targeted therapy of larynx cancer
498. immunotherapy in lung cancer
499. Chemotherapy-Induced Immune Modulation: Unraveling CAF-CD۴+ T Cell Interactions in Colorectal Cancer Pre- and Post- Treatment
500. The latest clinical trials and therapeutics for lip, oral cavity cancer: A Systematic Review
501. In silico Study of Peptide-Based Therapeutics in Colorectal Cancer Therapy
502. Novel Predictive Biomarkers Based on Non-coding RNAs in Corpus Cancer Immunotherapy
503. The expression of MiR۱۴۳-۳p on the MCF۷ and MDA-MB۲۳۱ cell lines after being treated with Epirubcin
504. Comprehensive Co-expression Network Analysis Identifies HSP۹۰AA۱ as a Potential Biomarker for Lymphatic Invasion and Prognosis of Infiltrating Ductal Carcinoma
505. In-Silico pathogenicity prediction of rs۲۱۴۵۲۶۳۶۴۲ in human CEBPA gene in Acute myeloid leukemia (AML)
506. Vitamins,the cure of colorectal Neoplasms
507. VEGF inhibitors for the treatment of colorectal cancer : A systematic review of clinical trials
508. Clarifying Hub mRNAs, lncRNAs and Gene Expression Profiles of colorectal cancer: An in-silico study
509. Intangible Genetic Heterogeneity in Cancer Survival: New Insights based on DNA methylation
510. Investigating the effect of oncolytic vaccinia virus: in vitro and mouse model of non-small cell lung carcinoma
511. Regulation of MicroRNA in Chronic Lymphocytic Leukemia (CLL): Mechanisms and Implications
512. Screening Metastatic Biomarkers in Colorectal Cancer Using Machine Learning and Predictive Modeling: In Silico Analysis and Experimental Validation
513. Expression alternation and function of small non-coding RNAs in Hodgkin Lymphoma cancer
514. Bioinformatic study of GPC۳ gene in liver cancer
515. Deciphering the Tumor Microenvironment in KRAS-Mutated Metastatic Colorectal Cancer Using Single-Cell RNA Sequencing
516. Single Cell Rnaseq Reveals Cell Heterogeneity and several gens as markers of High Fat Diet in C۵۷BL/۶ Mouse Model in cancer
517. The Key to Successful Immunotherapy in Osteosarcoma
518. Bioinformatics study of TK۱ gene in Breast cancer
519. Using the proteome method to detect cervical cancer
520. Beyond the COVID-۱۹ Vaccine: mRNA Vaccines in Cancer Treatment
521. Exploring the Alteration and Functional Roles of Small Non-Coding RNAs in Corpus Uteri Cancer
522. The Role of Personalized Medicine in Enhancing TIL Therapy for the Treatment of Melanoma
523. Exploring the Biomarker Potential of Differentially Expressed circRNAs in Endometrial Cancer
524. Potential of Natural Antioxidants for Upregulating Apoptosis in Cervical Cancer Cells: A Cellular and Molecular Study
525. Innovative Dictionary Learning and Sparse Coding for Effective Feature Selection in Cancer Gene Expression Data
526. Deciphering ceRNA Networks in AML Focused on NPM۱ Mutation
527. Investigating the effect of decreasing SLC۱۶A۱۳ gene expression on apoptosis and metastasis in Larynx cancer cell line
528. Evaluation of methylation changes and the expression of RASSF۲ gene in tumor tissue and tumor margins of colorectal cancer patients
529. NRP۱ gene expression changes in gastric cancer patients treated with doxycycline
530. The Impact of Tobacco Use on the Risk of Gingival Cancer in Individuals with a History of Periodontal Disease
531. The Impact of Human Papillomavirus (HPV) Type on Clinical Outcomes in Patients with Laryngeal Cancer
532. Ferritin as a Tumor Marker of Breast Cancer is Correlated with Tumor Severity
533. BRCA ۱/۲ mutations and risk of uterine cancer: a systematic review and meta-analysis
534. BCL-۲, IRS-۱, AKT-۳, PTEN, Survivin and HIF-۱A expression level in non-small cell lung cancer patients
535. Immunotherapy of ovary cancer with fungi
536. The inpatient interventions offered to terminally ill cancer patients registered in the MACSA home care system
537. Causes of cancer patients rehospitalization in end-of-life stages covered by MACSA home care facilities
538. The survey of home-based palliative care on the survival rate and place of death of cancer patients in the terminal phase of life
539. Explaining stakeholder's opinion about healthcare supports for cancer patients during the Covid-۱۹ pandemic: a qualitative study
540. How does spirituality play a role in the sense of coherence of cancer patients in supportive and palliative care settings? A review of Iranian patients’ lived experiences
541. Effectiveness of individual meaning-centered psychotherapy using the Breitbart method to decrease demoralization in women with advanced metastatic cancer
542. From adult to pediatric cancer: A new step from Iranian cancer control center (MACSA) as a charitable provider of supportive and palliative care in cancer treatment
543. Enhancing Supportive and Palliative Care Services for Children with Hematologic Malignancies
544. The Significance of Renewing Intensive Lymph Therapy Courses in the Prevention of Exacerbation and Recurrence of Breast Cancer Related Lymphedema (BCRL)
545. The Impact of Palliative supportive Care on the Psychosocial Well-being of Breast Cancer Patients with Lymphedema Referred to the Palliative Care Department at the Iranian Cancer Control Center (MACSA)
546. Play therapy: a novel approach in pain management of pediatric cancer
547. Fighting Against Pediatric Cancer: Provision of Supportive and Palliative Care in the Era of Solid Tumors
548. Telemedicine as a novel approach in Facilitating School Reintegration for Children with Cancer
549. The role of supportive care in educational status of children and adolescents with cancer
550. Application of machine learning in laboratory data of palliative care patients as the prospect of the Iranian cancer control center
551. Palliative care, an essential approach in personalized health care for elderly patients with cancer
552. Palliative and End of Life Care for Prisoners Suffering from Cancer
553. What is the status of Psychology Services in Iranian Cancer Control Center (MACSA)?
554. Role of supportive care in reentering to work in cancer patients
555. The importance of nutritionist in supportive and palliative care for cancer patients
556. The importance of sexual health in cancer patients
557. The Potential Role of Spirituality in Palliative Care for End-of-life Cancer Patients
558. The Role of Art Therapy in Supportive and Palliative Care for Cancer Patients
559. Pain management challenges in cancer patients receiving palliative care
560. Educational Status of Children with Cancer Referred to the MACSA Pediatric Palliative Care Department at Mofid Children's Hospital
561. The Impact of pediatric Cancer on Family members
562. The roles of hypnosis in symptom management of pediatric cancer
563. The potential association between a positive family history of breast cancer and the occurrence of lymphedema in a sample of ۳۰ patients treated at Fatemeh Zahra Hospital over a two-month period
564. The necessity of supportive and palliative care in the treatment of pediatric cancer patients
565. Cracking the Code: How Genetics Can Improve Supportive and Palliative Care for Cancer Patients and Their Families?
566. Serum creatinine level as a prognostic factor in palliative care patients with gastrointestinal cancer in end of life
567. Cultural Perspectives in Pain Management of Cancer Patients
568. Genetic and Epigenetic Biomarkers for Diagnosis and Prognosis of Head and Neck Cancer
569. Targeting DYRK۱B in triple-negative breast cancer: CRISPR-Cas۹ mediated knockout reveals potential for therapeutic intervention
570. In-Silico pathogenicity prediction of rs۳۷۴۶۲۱۴۲۵ in the BRMS۱ gene in breast cancer
571. The Molecular Mechanisms of Cisplatin Resistance in Ovarian Cancer
572. Deletion of the long non-coding RNA ANRIL in addition to the protein-coding genes of the INK۴ARF locus in the A۵۴۹ cell line: an existing phenomenon or a novel genetic alteration?
573. Production of Knockout Mice for DYRK۱B, ANRIL, and C۱ORF۱۳۲ Genes Using the CRISPR/Cas۹ System
